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Site-specific implantation in the milky spots of malignant cells in
peritoneal dissemination: immunohistochemical observation in mice
inoculated intraperitoneally with bromodeoxyuridine-labelled cells
H Tsujimoto, T Takahashi, A Hagiwara, M Shimotsuma, C Sakakura, K Osaki, S Sasaki,
M Shirasu, T Sakakibara, T Ohyama, A Sakuyama, M Ohgaki, T Imanishi and J Yamasaki
First Department ofSurgery. Kroto Prefectural University of Medicine, Japan.
Summan,- To investigate the site-specific implantation of cancer cells in pen'toneal dissemination, we
inoculated CDF1 mice intraperitoneally with mouse P388 leukaemia cells labelled with bromodeoxyuridine
(BrdU) and then observed immunohistochemically the distribution of the cells in the greater omentum taken
from the mice using an anti-BrdU antibody. We found the BrdU-labelled cells infiltrating selectively into the
milky spots in the omentum. Furthermore, we intraperitoneally inoculated the BrdU-labelled P388 cells at i0W.
106 and I10 cells per mouse into three groups of ten CDFI mice and then quantified the distribution of the
BrdU-labelled cells by counting the number of the labelled cells per unit area at each milky spot and
non-milky spot site in the omentum. Inoculations of IOW. 106 and 10' BrdU-labelled P388 cells per mouse
resulted in 15.8 ± 13.3. 120 ± 46.5 and 504 ± 208 cells mm-' respectively in the milky spot sites and
9.14 x 10-3 ± 1.58 x 10-', 1.14 x 10-1 ± 7.82 x 102 and 7.07 x 10- ±5.98 x 10-l cells mm ' respectively in
the non-milky spot sites. The ratios of the mean labelled cell numbers in the milky spot sites vs those in the
non-milky spot sites were 1728:1. 1049:1 and 713:1 respectively. In all cases, there were statistically significant
differences in the number of BrdU-labelled cells mm between milky spot sites and non-milky spot sites.
However, the ratios decreased as the numbers of inoculated cells increased. In addition, we inoculated C57 BL
mice intraperitoneally with B-16 PC melanoma cells, which were easily differentiated from the other cells bv
the intrinsic black melanin, and examined the distribution of the cells macro- and microscopically. The B-16
PC melanoma cells were also found to be infiltrating preferentially into the milky spots in the omentum. These
results suggest that cancer cells seeded intraperitoneally specifically infiltrate the milky spots in the early stages
of peritoneal dissemination.
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Milky spots are lymphoid tissue in the peritoneal cavity (Dux
et al., 1991). They are distributed mainly in the greater
omentum (Siefert, 1921), and are relatively rare in the
mesentery and the pelvic floor. Milky spots may contribute
to the peritoneal dissemination of cancer as sites of implanta-
tion. Some authors have reported that cancer cells infiltrate
milky spots in the early stages of peritoneal carcinomatosis in
experimental animals, based on light or electron microscopic
observations (Dux. 1969; Green and Williams. 1978). In a
previous report, we descnrbed the importance of the greater
omentum as a site of cancer implantation in peritoneal
dissemination, and also established a significant correlation
between the number of cancer cells infiltrating peritoneal
locations such as the greater omentum and the number of
milky spots at those peritoneal locations (Hagiwara et al.,
1993). In this study, we demonstrate that cancer cells selec-
tively infiltrate the milky spots by labelling with bromode-
oxyuridine (BrdU) followed by immunohistochemical stain-
ing (Gratzner, 1982). The site-specific implantation of cancer
cells into milky spots was quantitated by measuring the
distribution of the labelled cells especially in the omentum.
We demonstrated that B-16 PC melanoma cells inoculated
i.p. selectively infiltrated milky spots in the omentum without
labelling and specific staining.
Materials and methods
Cancer cell line and labelling with BrdU
Five-week-old male DBA2Cr and CDF1 mice (Shimizu
Laboratory Animal Center. Kyoto, Japan) were maintained
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under standard conditions (specific pathogen free, 22'C, 60%
relative humidity. 12 h day-night cycle). P388 leukaemia
cells were maintained through i.p. inoculation in DBA2
mice.
The ascites containing P388 leukaemia cells were taken
from the carrier DBA2 mouse, then were mixed with 0.83%
ammonium chloride in 20 mm 1' Tris buffer and were cen-
trifuged at 1000 r.p.m. for 5 min to remove the red blood
cells. After removing the fluid fraction, the cell fraction was
suspended at 106cellsml-' in culture medium (RPMI-1640;
Nissui Pharmaceutical, Tokyo. Japan) containing 10% fetal
bovine serum. This cell suspension was divided into four
bottles; three bottles contained BrdU (Radibud; Takeda
Chemical Industries, Osaka, Japan) at 0.5. 5 and 50 tgml-'
and the other contained no BrdU. The cells were incubated
at 37°C for up to 72 h.
After 12, 24, 48 and 72 h of incubation, 5 ml of cell
suspension was taken from each of the four bottles. After
centrifugation at 1000 r.p.m. for 5 min, the supernatants were
removed and the sediments were rinsed with phosphate-
buffered saline (PBS, 0.01 M, pH 7.4). The centrifuge and
rinse procedures were repeated three times in order to
remove the free BrdU completely. Cell viability and the
labelling index were then determined. Cell viabilities were
measured by the trypan blue exclusion test and the labelling
indexes were estimated for the smeared cells fixed in 4%
paraformaldehyde overnight by immunohistochemical stain-
ing using anti-BrdU antibody described below.
The cell viabilities and the labelling indexes of the P388
leukaemia cells, which were incubated under the various
conditions, are shown in Figure 1. From these data, we
found that optimal labelling in our study was achieved after
incubating the cells with BrdU at 5ILgmlm' for 24h. Cell
viability, which was 92.2 ± 1.9% (mean ± s.d., n = 3) after
labelling by this procedure, was essentially the same as that
of cells incubated without BrdU (91.8 ± 1.7%. n = 3). The
labelling index of 76.7 ± 1.5% (n = 3) under these conditions
was nearly maximum. Thereafter, all subsequent studies weresi9-specific ip ti bt milky spots
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Figure 1 Cell viabilitv and labelling index of P388 cells
incubated under various conditions. (a) The viability of cells
incubated with BrdU at various concentrations (-E-. 0.5 jug
ml-' 0 5 jg ml-', - -A- -. 50 Ig ml-') or without BrdU
(0). (b) Labelling index of the cells incubated with various
concentrations of BrdU. Arrows show the viability and the labell-
ing index under the condition of labelling with BrdU at 5 lAg ml-'
for 24 h.
performed with cells incubated with BrdU at 5 iLg ml-' for
24h.
In another control experiment, we estimated the effect of
BrdU on the malignant potential of P388 leukaemia cells. To
this end, the P388 cells were incubated with BrdU at 5 jLg
ml for 24 h and were suspended in saline at a concentra-
tion of 106cells ml-'. A 1 ml aliquot of the suspension was
inoculated i.p. into each of 20 CDF1 mice. The same number
of mice were similarly injected with P388 cells cultured in the
absence of BrdU for 24 h. The number of survivors in each
of the two groups was checked daily. The survival curves are
shown in Figure 2. There was no significant difference
between the two groups (P> 0.05, generalised Wilcoxon test).
This suggested that labelling with BrdU under these condi-
tions did not affect tumour growth.
Preparation ofgreater omentum and immunohistochemical
staining
P388 cells incubated with BrdU as described above (BrdU-
labelled cells) were suspended in saline at a concentration of
106cells mln. A 1 ml aliquot of the suspension was inocu-
lated i.p. into each of five CDF1 mice. Control mice received
the same number of P388 leukaemia cells that had been
incubated in the absence of BrdU for 24 h (control cells).
These mice were sacrificed 24 h after inoculation. In prepara-
tion for immunohistochemical staining, the greater omenta of
the mice were removed, prepared as stretch specimens and
fixed with 4% paraformaldehyde in 0.1 M phosphate buffer
(PB. pH 7.4) overnight at 4'C.
Survival time (days)
Figure 2 Survival curves of mice inoculated with 106 BrdU-
labelled cells (0) (incubated with BrdU at 5 jig ml' for 24 h)
and 106 control cells (0) (incubated without BrdU for 24 h).
There was no significant difference between these two groups
(P>0.05. generalised Wilcoxon test).
After washing in PB containing 0.3% Triton-X 100 for 2 h
and rinsing in PBS for 30 min, endogenous peroxidase
activity of the specimens was blocked with methanol contain-
ing 1% hydrogen peroxide for 30 mn. Following rinses in
PBS. the specimens were reacted with 2 N hydrochloric acid
for 30 min and 0.1 M sodium borate for 5 mn. The speci-
mens were then incubated for 48 h at 4°C with monoclonal
rat anti-BrdU antibody (Anti-Bromodeoxy-uridine; Biotrin
International. Compiegne. France) diluted in PBS (1:500).
The specimens were rinsed and were incubated for 2 h with
biotinylated secondary antibody (anti-rat IgG immunoglobulin
in the Bectastain ABC kit. Vector Laboratories. Burlingame,
CA. USA). The secondary antibody was prepared by incuba-
tion overnight with mouse serum diluted (1:10) in PBS and
centrifugation at g for I h in order to remove the
elements reacting with mouse immunoglobulins. After rinsing
in PBS, the specimens were incubated with an avidin-
biotin-peroxidase complex (Bectastain ABC kit. 1:100) for
3 h. After another rinse in PBS, the specimens were reacted
with 3,3'-diaminobenzidine (DAB, Sigma, St Louis, MO.
USA) at a concentration of 0.5 mg nil- in Tris-HCI buffer.
pH 7.6. containing 0.02% hydrogen peroxide. for 10 min.
For final preparation, the specimens were counterstained
with methyl green, dehydrated and mounted for stereo-
microscopic observations. All staining procedures were car-
ried out at room temperature. except for the incubation with
the primary anti-BrdU antibody.
Counting the number ofBrdU-labelled P388 cells
The number of cancer cells infiltrating into the milky spots or
other parts of the omentum was determined as follows. After
incubating with BrdU at 5 jig ml-' for 24 h, the BrdU-
labelled cells were inoculated i.p. into three different groups
of ten mice at either 105, 106 or 107 cells per mouse. Twenty-
four hours later the greater omentum was removed from
each mouse, fixed in paraformaldehyde and stained immuno-
histochemically by the method described above. By using
two-dimensional measurement software (Cosmozone I SA.
Nikon. Japan), the number of BrdU-labelled cells per unit
area was measured separately at milky spot sites and non-
milky spot sites, which consist of serous membranes, adipose
tissues and blood vessels. The counting procedure involved
initially determining the total areas of the milky spot sites
and the non-milky spot sites in each specimen, and then the
number of the BrdU-labelled cells at each of the sites was
measured separately. Finally the results were expressed as the
number of BrdU-labelled cells per mm2. The results were
compared statistically by paired t-test.
Histological observation ofB-16 PC melanoma cell infiltration
The mouse B-16 PC melanoma cell line, which was establish-
ed from the standard B-16 melanoma through serial intra-
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peritoneal inoculation (24 times) in our laboratory and main-
tained by cell culture (RPMI-1640) in vitro, easily induces
peritoneal dissemination by intraperitoneal inoculation. After
harvesting by treatment with a 0.25% trypsin solution, B-16
PC melanoma cells at 10' per mouse were inoculated intra-
peritoneally into ten mice (5-week-old male C57/BL; Shimizu
Laboratory Animal Center). Two and 10 days after inocula-
tion, five mice were sacrificed and the intraperitoneal distri-
bution of the tumour cells were observed macroscopically
and microscopically. We then examine the greater omentum
using its stretch specimens stained with methyl green in
order to distinguish black melanoma cells from the other
cells.
Res
Microscopic observation ofP388 cell infiltration
The greater omentum consisted of blood vessels, perivascular
adipose tissue, serous membrane and milky spots. The milky
spots were readily distingis microopally from other
components of greater omentum, because milky spots exist
along with blood vessels and consist of many aggregating
cellular components such as macrophages, lymphocytes and
mast cells (Dux, 1990), whereas the serous membranes con-
sisted of a loose arrangement of mesothelial cells.
Figure 3 shows the microscopic viws of the greater
omenta which were taken from the mice inoculated i.p. with
10' BrdU-labelW cells or 10' control cells stained immuno-
histochemially using the anti-BrdU antibody. Figure 3a and
b shows the greater omentum taken from mice that received
10' BrdU-labelled cells. A large number of the BrdU-labeLed
cls stained brown selectively infiltrated the milky spots,
which are the accumulation of green nuclei. Only a few
labelled cells could occasionally be seen in the serous mem-
branes. However, in the omenta taken from control mice, the
labelled cells stained brown were seen at neither milky spots
nor the other sites (Figure 3c and d).
Nwnber ofinfiltrating P388 cellsper unit area in tissue
Since the BrdU-labeUled cells were clearly distinguishable
from the other cells at the milky spots and other structures in
the greater omentum, they were easily counted even when a
large number ofcells were inoculated. The numbers of BrdU-
labelled cells per unit area (mm2) in the milky spot sites and
the non-milky spot sites are shown in Table I. When I0O cells
were inoculated i.p., 15.8 ± 13.3 labeled cellsmm-2 (mean +
s.d., n = 10) were found in the milky spot sites and 9.14 x
10-3± 1.58 x 102cells mm-2 were detected in the non-milky
spot sites. Inoculation of 10' cells produced 120 ± 46.5
labelled cells mm 2 in the milky spot sites and 1.14 x 10-1 +
7.82 x 10-1 cellsmm-2 in the non-milky spot sites. In mice
receiving I07 cells, the numbers of labelled cells increased to
504 ± 208 cellsmm-2 in the milky spot sites and 7.07 x
10-' ± 5.98 x 10-' in the non-milky spot sites. The ratios of
the mean labeLled cell number in the milky spot sites vs that
in the non-milky spot sites were 1728:1, 1049:1, and 713:1
respectively. In all cases, there were statistically significant
differences in the number of BrdU-labelled cellsmm-2
between milky spot sites and non-milky spot sites (paired
t-test).
Fugwe 3 Immunohistolgy of P388 Ieknia cells in the greater omentum ofmice inoculated with 10' BrdU-labelled cells or 10'
control celIs (a and c x 20, b and d x 50). (a and b). Microscopic views of the greater omentum taken from mice that rui ved 10'
BrdU-labelled cells A large number of the BrdU-labelled cells staned brown selctvely infilt d the milky spots, which are the
accumulation ofgree nuclei (large arrows). In contrast, a few labelld cells could ocasioy be seen at serous membranes (small
arrows). (c and d) Microscopic viws of the greater omentum of mice inoculated wnth 10' control cells No Labeed cells were seen
at either milky spots or the other sites. (Large arrows show milky spots).
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Table I Number of BrdU-labelled cells in milky spot and non-milky spot sites
Number of Nunber of labelled cells Number of labelled cell in
inoculated cell in milky spot sites' non-milky spot sites' P-valuec
(cells) (cells±s.d. mm'2) (cells±s.d. mm2} Ratiob (paired t-test}
i05 15.8 ± 13.3 9.14 x 10-3_ 1.58 x 10-2 1728:1 <0.05
106 120 ± 46.5 1.14 x 10-'±7.82 x 10-2 10491 <0.01
10 504±208 7.07x 10-'±5.98x 10-' 713:1 <0.01
'The number of infiltrating cells mm in milky spot or non-milky spot sites was calculated from ten
specimens of greater omenta taken from ten mice inoculated with a different number of BrdU-labelled
cells. 'The given ratios were calculated from the mean number of the labelled cells in the milky spot
sites vs that in the non-milky spot sites respectively. 'Statistical significances were estimated from the
number of BrdU-labelled cells between milky spot sites and non-milky spot sites using paired t-test.
Histological observation ofB-16 PC melanoma infiltration
After observation of the mice sacrificed 2 days after inocula-
tion of B-16 PC melanoma, we could find no macroscopic
tumour intraperitoneally. However, microscopic study of the
greater omentum showed many black melanoma cells
infiltrating the milky spots. In contrast, in the other sites only
a few melanoma cells could be seen (Figure 4a). In mice
sacrificed 10 days after inoculation, we could detect some
very small black tumour nodules macroscopically in the
omeitum, the mesentery and the gonadal fat. Microscopic
observation of the omentum revealed that the black
melanoma cells formed some large clusters at the milky spots
and a few smaller ones at the non-milky spot sites (Figure
4b).
Disass
Milky spots are lymphoid tissue in the peritoneal cavity (Dux
et al., 1991) and are considered to be gates through which
small particles are absorbed from the peritoneal cavity into
the subperitoneum (Higgins and Bain, 1930). These milky
spots are found mainly in greater omentum (Seifert, 1921),
with relatively fewer of them appearing in the mesentery and
the pelvic floor; no milky spots are found in other areas of
the peritoneum (Hagiwara et al., 1993). Milky spots may
contribute to the peritoneal dissemination of cancer as sites
of implantation. Some authors have reported that cancer
cells infiltrate the milky spots in the early stages ofperitoneal
carcinomatosis in animal experiments (Dux, 1%9; Green and
Williams, 1978). The reason for this site-specificity of
peritoneal carcinomatosis probably relates to the function of
milky spots as gates through which small particles are trans-
ferred from the peritoneal cavity to the subperitoneum (Hig-
gins and Bain, 1930). In addition, the cancer cells may
readily adhere to the milky spots, since milky spots lack
mesothelial cells (Beelen et al., 1980).
However, those reports were based solely on subjective
light or electron microscopic observations. No attempt has
been made using human or animal experiments to quantify
the numbers of viable cancer cells infiltrating the peritoneum
at specific locations such as milky spots, because of the
difficulties in determining the numbers of viable cancer cells
infiltrating peritoneal tissues. In a previous report, we des-
cribed the importance of greater omentum as a site of
implantation of viable cancer cells in peritoneal dissemina-
tion, and also established a significant correlation between
the number of cancer cells infiltrating peritoneal locations
such as the greater omentum and the number of milky spots
at those peritoneal locations by using a new experimental
approach (Hagiwara et al., 1993). In the present study, in
order to corroborate these results, by labelling with bromo-
deoxyuridine (BrdU) and by immunohistochemical staining
(Gratzner, 1982) we demonstrated that cancer cells selectively
infiltrate milky spots. Furthermore, we quantitatively evalu-
ated the site-specific implantation of cancer cells into milky
spots by measuring the distribution of the labelled cells,
especially in the omentum. In the omentum it was possible to
compare the distribution of the BrdU-labelled cells in milky
Fugwe 4 Histology of the greater omentum of mice inoculated
i.p. with 106 B-16 PC melanoma cells (a x 20, b x 5). (a) Micro-
scopic viw of the greater omentum taken from a mouse sacrificed
2 days after inoculation with B-16 PC melanoma cells. Many
black melanoma cells selectively infiltrated the milky spots, which
are the accumulation of green nuclei (large arrows). In contrast,
only a few black melanoma cells can occasionally be seen at
serous membranes (small arrows). (b) Microscopic view of the
greater omentum of a mouse sacrificed 10 days after inoculation.
At the milky spots, B-16 PC melanoma cells form large black
nodules (large arrow). At the serous membrane site, a few smaller
nodules of melanoma cells can be seen (small arrows).
spot and non-milky spot sites because omentum contains
many milky spots and some other common components of
peritoneal tissues such as serous membranes and adipose
tissues.
We found immunohistochemically a large number of
BrdU-labelled cells selectively infiltrating the milky spot sites
after the inoculation of 106 labelled cells. However, a few
labelled cells were also detected at other sites in the omen-
tum. In addition, the ratios of the mean labelled cell number
in the milky spot sites vs that in the non-milky spot sites
decreased as the numbers of inoculated cells increased. Thesex%
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results suggest that a small number of cancer cells floating in
the pen'toneal cavity tend to infiltrate the milky spots selec-
tively. especially during the early stages of peritoneal car-
cinomatosis.
In the present study, we used P388 leukaemia cells as an
experimental tumour, as in our previous experiments (Hagi-
wara et al.. 1993). This is because this cell line is a very
useful experimental model of cancer metastasis to the
regional lymph nodes or peritoneal cavity since there is a
linear correlation between the survival time of mice and
logarithm of the number of P388 cells inoculated into the
peritoneum (Tsuruo et al., 1980: Hagiwara et al., 1993).
Another reason is that these tumour cells are readily
identified and counted microscopically after immunohisto-
chemical staining since they rarely form clusters and are
dispersed throughout the peritoneal cavity. In addition, the
stretched omental preparation that we used in this study also
has significant advantages over paraffin-embedded or frozen
specimens. With stretch specimens it is possible to observe
the whole greater omentum clearly and completely because of
its transparency (Shimotsuma et al., 1991; Dux et al.. 1993),
but paraffin-embedded or frozen specimens provide a rather
restricted view of the omentum. By using P388 leukaemia
cells and immunohistochemical staining of the stretch speci-
mens of the greater omentum, we could quantitatively
analyse site-specific implantation of i.p. inoculated cancer
cells to the milky spots in the omentum. Labelling with BrdU
may alter the physiology of cancer cells. However, the proce-
dure that we developed for labelling cells with BrdU at
5 tLg ml-' for 24 h gave an adequate labelling index for
immunohistochemical staining with the stretch specimens and
was not detrimental to cell viability such that substantial
infiltration of cancer cells into the peritoneal tissues occur-
red.
Finally, we examined intraperitoneally the distribution of
the B-16 PC melanoma cell line after i.p. inoculation. Since
this cell line contains intrinsic black melanin. it could easily
be differentiated from other cells and observed its natural
state without labelling and specific staining. Macroscopically.
we found that the melanoma forms tumour clusters especially
in the omentum, mesentery and gonadal fat. in which milky
spots are distributed. Microscopically. we could demonstrate
that the melanoma cells preferentially infiltrated milky spots
in the omentum and became established there. This result
leads to the conclusion that milky spots are very important
implantation sites for peritoneal dissemination.
The results in this study suggest that cancer cells seeded
i.p. specifically infiltrate milky spots during the initial stage
of peritoneal metastasis.
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